Natera, INC Form 4 insider transactions

Natera's CFO, Michael Burkes Brophy, executed multiple sales of common stock on May 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

John Fesko, President and Chief Business Officer of Natera, Inc., sold 929 shares of common stock on April 29, 2024, to cover tax obligations related to vesting RSUs.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 1,196 shares of common stock on April 29, 2024, to satisfy tax withholding obligations related to vesting RSUs.

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., sold 1,057 shares of common stock on April 29, 2024, to cover tax obligations related to vesting RSUs.

Natera's CEO, Steven Chapman, sold 4,084 shares of common stock on April 29, 2024, at a price of $93.1387 per share to cover tax obligations related to vesting RSUs.

Michael Brophy, CFO of Natera, Inc., sold 1,238 shares of common stock on April 29, 2024, to satisfy tax withholding obligations related to vesting RSUs.

Director James Healy received 210 Restricted Stock Units (RSUs) from Natera, Inc. in lieu of quarterly retainer fees.

Director Roy D. Baynes acquired 169 shares of Natera, Inc. common stock through the issuance of fully vested Restricted Stock Units (RSUs) in lieu of quarterly retainer fees.

Director Marcus Gail Boxer acquired 488 Restricted Stock Units (RSUs) of Natera, Inc. on April 26, 2024, which vest over one year.

Director Rowan E. Chapman acquired 488 shares of Natera, Inc. through the issuance of Restricted Stock Units (RSUs) on April 26, 2024.

Director Rosenman Herm of Natera, Inc. reports acquiring common stock and restricted stock units (RSUs) on April 26, 2024, according to a Form 4 filing with the SEC.

Director Roelof Botha reports acquisition of Natera, Inc. stock through restricted stock units (RSUs).

Jonathan Sheena, co-founder of Natera, Inc., sold 1,000 shares of common stock on April 25, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Natera's CFO, Michael Brophy, executed multiple sales of common stock between April 24 and April 26, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., reports transactions involving common stock and restricted stock units.

Daniel Rabinowitz, SEC and Chief Legal Officer of Natera, Inc., reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 531 shares of common stock to cover tax obligations related to vesting RSUs.

John Fesko, President and Chief Business Officer of Natera, Inc., sold 522 shares of common stock on April 23, 2024, to cover tax obligations related to vesting RSUs.

Natera's CEO, Steven Chapman, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Michael Brophy, CFO of Natera, Inc., reports the vesting and sale of restricted stock units to cover tax obligations.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold a total of 80,000 shares of common stock on April 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Natera's CEO, Steven Chapman, sold shares of the company's common stock on April 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., sold shares of common stock on April 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Natera's CFO, Michael Brophy, sold 1,378 shares of common stock on April 2, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., reports the acquisition and disposition of common stock and restricted stock units.

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., reports the vesting of Restricted Stock Units and subsequent sale of shares to cover tax obligations.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 707 shares of common stock to cover tax obligations related to vesting RSUs.

John Fesko, President and Chief Business Officer of Natera, Inc., sold 464 shares of common stock on March 28, 2024, to satisfy tax withholding obligations related to vesting RSUs.

Natera's CEO, Steven Chapman, executed multiple sales of common stock in March 2024 under a pre-arranged Rule 10b5-1 trading plan and to cover tax obligations related to vesting RSUs.

Michael Brophy, CFO of Natera, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.